• Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A Update with Zack Bozinovski
  • Contact
  • Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A Update with Zack Bozinovski
  • Contact
WNX-Small Caps-3

Wellnex Life directors commit $1.5m to current entitlement offer

The directors of diverse consumer healthcare business Wellnex Life (ASX: WNX) have committed to subscribe...

WNX-Small Caps-1

Wellnex Life secures $14.3m for dual listing on London Stock Exchange

Wellnex Life (ASX: WNX) has secured conditional binding commitments to raise $14.3 million to fund...

WNX-London

Wellnex Life raises $9m ahead of proposed London Stock Exchange AIM listing

Healthcare business Wellnex Life (ASX: WNX) has received initial conditional binding commitments of $9 million...

WNX-Small Caps 20250402

Wellnex Life expands global reach with UK market entry and new product approval

Wellnex Life (ASX: WNX) has achieved another breakthrough in its expansion plans with a new...

WNX - Small Caps

Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE

Wellnex Life (ASX: WNX) has reported record sales of $3 million per month for November...

small caps

Wellnex Life on track to meet guidance as sales continue to grow

Consumer healthcare business Wellnex Life (ASX: WNX) has announced it is on track to meet its guidance...

Wellnex-Life-ASX-WNX-medicinal-cannabis-Special-Access-Scheme-Category-B-SAS-B-Chemist-Warehouse-OneLife-Botanicals

Wellnex Life to launch medicinal cannabis products into emerging SAS-B market with Chemist Warehouse

Customer-focused healthcare company Wellnex Life (ASX: WNX) has unveiled plans to launch medicinal cannabis products into Australia’s...

Wellnex-Life-ASX-WNX-Pharmacy-Own-CH2-Clifford-Hallam-Healthcare

Wellnex Life delivers first batch of Pharmacy Own products to exclusive distributor

Health and wellness company Wellnex Life (ASX: WNX) has delivered the first batch of its Pharmacy Own...

Wellnex-Life-ASX-WNX-e-commerce-platform-TheSet.Co-business-to-consumer-model-B2C

Wellnex Life launches online retail platform targeting active lifestyle B2C market

Wellnex Life (ASX: WNX) has launched a one-stop platform and brand known as TheSet.Co which will...

Wellnex-Life-ASX-WNX-bank-balance-fund-over-the-counter-medicinal-cannabis-product-plans-OneLife-Botanicals

Wellnex Life tops-up bank balance with $6m to fund over-the-counter medicinal cannabis product plans

Wellnex Life (ASX: WNX) has raised almost $6 million via a capital raising and strategic investment...

Posts pagination

Previous1 2 Next
RECENT POSTS
  • Wellnex Life expects growth to continue through year as revenue surges
  • Wellnex Life debuts in London with successful AIM IPO
  • Sydney-listed Wellnex Life starts trading on AIM market in London
  • The London Stock Exchange Today Welcomes Wellnex Life Limited
  • Wellnex Life on track for UK listing after raising £7.3m
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2025 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)